Loading asset research
Onconetix Inc. Common Stock
ONCONasdaq · USD · StocksQuote as of · Exchange session not verified$1.03
+12.90%
Today
ONCO
Loading 1D prices…
Market cap
$4.5M
Volume
47.6M
52w high
$209.5052w low
$0.586Company profile
Onconetix Inc. Common Stock
Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, the European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. It has a license agreement with LabCorp to develop and commercialize Proclarix and other products; and with Immunovia AB for the development, manufacturing, and commercialization of the PancreaSure test. The company was formerly known as Blue Water Biotech, Inc. and changed its name to Onconetix, Inc. in December 2023. Onconetix, Inc. was founded in 2018 and is headquartered in Cincinnati, Ohio.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
Cincinnati, OH, United States
Employees
2
Fiscal year end
1231
CIK
1782107
Session & valuation
Open$1.12
Previous close$0.911
Day high$1.42
Day low$1.00
30-day avg. volume3.3M
Outstanding shares3.9M
Diluted EPS-$16.56
Latest annual period
P/E (trailing)0.00
P/E (forward)-1.21
Price / book0.29
Beta2.67
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| GRIGRI Bio Inc. Common Stock | $4.5M | $0.00 | — | -$121.80 | -1.91% | Buy |
| ADXNAddex Therapeutics Ltd American Depositary Shares | $4.6M | — | — | -$7.20 | +4.05% | Unrated |
| CANFCan-Fite Biopharma Ltd American Depositary Shares each representing two (2) Ordinary Shares | $4.6M | $405K | -2426.67% | -$5.97 | -0.46% | Buy |
| SXTP60 Degrees Pharmaceuticals Inc. Common Stock | $4.1M | $1M | -732.51% | -$11.73 | +1.74% | Hold |
| CVKDCadrenal Therapeutics Inc. Common Stock | $4.1M | $0.00 | — | -$6.64 | -4.17% | Buy |